Top of the Street: Aena, Ashtead Group, Coloplast, Evonik, IAG

Coloplast A/S

11/12/2024 13:46

A round-up of notable broker activity this morning from Europe's
top-ranked* analysts:
    
        ** UBS and Deutsche Bank cut their ratings on Spanish
airport operator Aena  AENA.MC  by one notch to "neutral" and
"sell," respectively, seeing limited scope for a re-rating in
the near term
        ** Goldman Sachs downgrades Ashtead Group  AHT.L  to
"neutral" from "buy" following the British equipment rental
company's Q2 miss and guidance cut, seeing risks to revenue
growth for FY 2025 and FY26
    ** UBS raises Denmark's Coloplast  Colob.CO  to "neutral"
from "sell," seeing the risk-reward for the medical equipment
maker's shares as "better matched" now
    ** Morgan Stanley cuts Germany's Evonik  EVKn.DE  to
"underweight" from "equal weight" as it sees limited near-term
profit recovery scope, in contrast to its chemical producers
peers 
    ** Deutsche Bank raises Britain's International Airlines
Group  ICAG.L  to "buy" from "hold" as it anticipates further
progress on pricing in 2025 thanks to constrained capacity on
the Transatlantic route, a key market for the British Airways-
owner
    ** J.P. Morgan raises France's Publicis  PUBP.PA  to
"overweight" from "neutral" as it expects the media group's
strong US exposure to drive more than 5% growth, triple that of
its peers
    
(*Analyst rankings from Thomson Reuters StarMine. The scale is
from 1-star to 5-star with 5 being the best. Analysts are ranked
on earnings accuracy as well as relative performance of
recommendations over trailing 12-month & 24-month periods.)


 (Reporting by Philippe Leroy Beaulieu and Joao Manuel Mauricio)
 ((Philippe.leroybeaulieu@thomsonreuters.com))